PLA2G7 anticorps

N° du produit ABIN7176818

Cet anticorps Souris Monoclonal détecte spécifiquement PLA2G7 dans WB, ELISA et IHC. Il présente une réactivité envers Humain.

Aperçu rapide pour PLA2G7 anticorps (ABIN7176818)

Antigène: PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp PLA2G7 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Clone: 2A1B6

Détail du produit anti-PLA2G7 anticorps

Réactivité croisée: Humain, Souris

Purification: Protein G purified

Immunogène: Recombinant LP-PLA2 Protein

Isotype: IgG1, IgG1 kappa

Information d'application

Indications d'application: Recommended dilution:WB:1:500-1:5000,IHC:1:50-1:500,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur PLA2G7

Antigène: PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))

Autre désignation: PLA2G7

Sujet:

Background: Platelet-activating factor acetylhydrolase deficiency (PAFAD) : An enzymatic deficiency that results in exacerbated bodily response to inflammatory agents. It can be associated with several disease states including inflammatory gastrointestinal disorders, asthma and atopy. Asthmatic individuals with PAFAD may manifest aggravated respiratory symptoms.

Aliases: PLA2G7, PAFAH, LP-PLA2

UniProt: Q13093

Pathways: Peptide Hormone Metabolism